Global Postmenopausal Vaginal Atrophy Clinical Trials Review 2015 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/2cm9kp/postmenopausal)
has announced the addition of the “Postmenopausal
Vaginal Atrophy Global Clinical Trials Review, H2, 2015″ report
to their offering.

Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2015
provides an overview of Postmenopausal Vaginal Atrophy clinical trials
scenario. This report provides top line data relating to the clinical
trials on Postmenopausal Vaginal Atrophy. Report includes an overview of
trial numbers and their average enrollment in top countries conducted
across the globe.

The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials).

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by
  Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
  End point status
• The report reviews top companies involved and enlists all trials
  (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated,
  Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Key Topics Covered:

1. List of Tables
2. List of Figures
3. Report Guidance
4. Clinical Trials by Region
5. Clinical Trials and Average Enrollment by Country
6. Top Countries Contributing to Clinical Trials in Asia-Pacific
7. Top Five Countries Contributing to Clinical Trials in Europe
8. Top Countries Contributing to Clinical Trials in North America
9. Top Countries Contributing to Clinical Trials in Middle East and Africa
10. Top Countries Contributing to Clinical Trials in Central and South
    America
11. Clinical Trials by G7 Countries: Proportion of Postmenopausal Vaginal
    Atrophy to Women’s Health Clinical Trials
12. Clinical Trials by Phase in G7 Countries
13. Clinical Trials in G7 Countries by Trial Status
14. Clinical Trials by E7 Countries: Proportion of Postmenopausal Vaginal
    Atrophy to Women’s Health Clinical Trials
15. Clinical Trials by Phase in E7 Countries
16. Clinical Trials in E7 Countries by Trial Status
17. Clinical Trials by Phase
18. In Progress Trials by Phase
19. Clinical Trials by Trial Status
20. Clinical Trials by End Point Status
21. Subjects Recruited Over a Period of Time
22. Clinical Trials by Sponsor Type
23. Prominent Sponsors
24. Top Companies Participating in Postmenopausal Vaginal Atrophy
    Therapeutics Clinical Trials

• Novo A/S
• Shionogi & Co., Ltd.
• Quatrx Pharmaceutical Company
• Hormos Medical
• Pfizer Inc.
• Italfarmaco S.p.A.
• Duramed Research Inc.
• Allergan Plc
• Abbott Laboratories
• A+ Science AB

For more information visit http://www.researchandmarkets.com/research/2cm9kp/postmenopausal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women’s
Health, Clinical
Trials